We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+29.13%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$244M
AUM Growth
+$22M
Cap. Flow
+$5.32M
Cap. Flow %
2.18%
Top 10 Hldgs %
43.92%
Holding
93
New
19
Increased
15
Reduced
7
Closed
46

Top Buys

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$10.8M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$9.94M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$9.37M
4
BLUE
bluebird bio
BLUE
+$9.25M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$8.83M

Top Sells

Rank Stock Value
1
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$13.4M
2
AGN
Allergan plc
AGN
+$10.2M
3
GILD icon
Gilead Sciences
GILD
+$6.87M
4
CELG
Celgene Corp
CELG
+$6.49M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$5.71M

Sector Composition

Rank Sector Weight
1 Healthcare 95.9%
2 Miscellaneous 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHMA
76
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-65,000
Closed -$1.29M
GWPH
77
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-30,000
Closed -$2.74M
AGN
78
DELISTED
Allergan plc
AGN
– –
-37,500
Closed -$10.2M
FOMX
79
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-150,000
Closed -$1.1M
ONCE
80
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-10,000
Closed -$417K
GNCA
81
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-27,500
Closed -$1.51M
HZNP
82
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-275,000
Closed -$5.45M
AEGR
83
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-250,000
Closed -$3.4M
RLYP
84
DELISTED
RELYPSA INC COM
RLYP
– –
-120,000
Closed -$2.22M
HTWR
85
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-90,000
Closed -$4.71M
UNIS
86
DELISTED
Unilife Corporation
UNIS
– –
-35,000
Closed -$343K
ZGNX
87
DELISTED
Zogenix, Inc.
ZGNX
– –
-370,000
Closed -$5M
BDSI
88
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-106,200
Closed -$590K
BDSI
89
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-100,000
Closed -$556K
CELG
90
DELISTED
Celgene Corp
CELG
– –
-60,000
Closed -$6.49M
NDRM
91
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
– –
-100,000
Closed -$2.07M
DSCI
92
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
– –
-300,000
Closed -$1.41M
RPTP
93
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
– –
-50,000
Closed -$303K
1 2 3
4

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Ghost Tree Capital held 93 positions worth $244M, up 9.9% from $222M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ghost Tree Capital's Q4 2015 filing shows 19 new, 15 increased, 7 reduced and 46 closed positions. Its largest new stake was Wright Medical Group Inc: 500,000 shares worth $12.1M. The largest sale was Five Prime Therapeutics, Inc., an estimated $13.4M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 85% a quarter earlier, followed by Miscellaneous.

  • Ghost Tree Capital's largest Q4 2015 buy was Wright Medical Group Inc: 500,000 shares worth $12.1M.
  • Ghost Tree Capital added most to Portola Pharmaceuticals, Inc. in Q4 2015, an estimated $9.94M increase.
  • Ghost Tree Capital's biggest Q4 2015 reduction was Five Prime Therapeutics, Inc., cutting an estimated $13.4M.
  • Ghost Tree Capital fully exited Allergan plc in Q4 2015, selling an estimated $10.2M.
  • Ghost Tree Capital's ten largest holdings make up 44% of its $244M portfolio in Q4 2015.
  • Ghost Tree Capital opened 19 new positions and closed 46 in Q4 2015.
  • Ghost Tree Capital's portfolio value rose 9.9% quarter-over-quarter to $244M.

Based on Ghost Tree Capital's 13F filing for Q4 2015, filed 16 Feb 2016.